Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Panel Discusses Extreme Weather’s Effect On Medical Device Availability

This article was originally published in The Gray Sheet

Executive Summary

FDA’s Device Good Manufacturing Practice Advisory Committee met April 11 to help the agency develop better policies to prepare for and respond to extreme weather conditions that impact medical devices.

You may also be interested in...



FDA Examines Extreme Weather Impact On Device Supply Chains

The agency called an advisory committee meeting and public comment period to collect feedback from device firms and others on effects that extreme weather and natural disasters pose to medical device safety and quality.

HHS Innovation Project To Develop More Resilient DME For Natural Disasters

Over the next six to 12 months, a team working through HHS’ Innovation Fellows Program will develop medical technology capable of withstanding natural disasters.

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031973

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel